• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
YANG Xiaojun, AI Fengfeng, LIN Junbing, TANG Jiangjiang. Chemical constituents extracted from Dictamnus dasycarpus and their α-glucosidase inhibitory activity[J]. Journal of China Pharmaceutical University, 2019, 50(1): 41-45. DOI: 10.11665/j.issn.1000-5048.20190105
Citation: YANG Xiaojun, AI Fengfeng, LIN Junbing, TANG Jiangjiang. Chemical constituents extracted from Dictamnus dasycarpus and their α-glucosidase inhibitory activity[J]. Journal of China Pharmaceutical University, 2019, 50(1): 41-45. DOI: 10.11665/j.issn.1000-5048.20190105

Chemical constituents extracted from Dictamnus dasycarpus and their α-glucosidase inhibitory activity

More Information
  • Five compounds were isolated from the petroleum ether extract of Dictamnus dasycarpus using various chromatographic techniques, such as column chromatography over silica gel and Sephadex LH-20. Their structures were elucidated by spectroscopic data(IR, MS, NMR), which were identified as docosanol( 1 ), ethyl 2, 2-dibenzhydryl-3, 3-di-phenylpropionate( 2 ), limonin( 3 ), obacunone( 4 )and dictamnine( 5 ). Compound 2 was a new compound and compound 1 was isolated from this plant for the first time. PNPG method was used to determine α-glucosidase inhibitory activity of these compounds. The results indicated that compounds 3 - 5 possessed stronger inhibitory activities than the positive control of acarbose, which provided a theoretical basis for further development and utilization of Dictamnus dasycarpus.
  • [1]
    Xu SS,Zhang HB,Zhou JP,et al.Advances of new antidiabetic drugs[J].J China Pharm Univ(中国药科大学学报),2011,42(2):97-106.
    [2]
    Lyann S,Kumarasamy J,Sankar M,et al.New glucosidase inhibitors from an ayurvedic herbal treatment for type 2 diabetes:structures and inhibition of human intestinal maltase-glucoamylase with compounds from Salacia reticulate[J].Biochemistry,2010,49(3):443-451.
    [3]
    Avogaro A,Fadini GP.The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications[J].Diabetes Care,2014,37(10):2884-2894.
    [4]
    Lin YP,Zong YL,He H,et al.Chemical constituents of the aerial parts of Seseli yunnanense Franch[J].Nat Prod Res Dev(天然产物研究与开发),2007,19:798-800,836.
    [5]
    Qu JY,Wang MY,Wang CM,et al.Anti-inflammatory fraction and chemical constituents of Hosta plantaginea[J].Chin Tradit Herb Drugs(中草药),2011,42(2):217-221.
    [6]
    Andrew PB III,Klaus D,Rosalind YW.Isolation and identification of the first C-17 limonin epimer,epilimonin[J].J Agric Food Chem,2008,56(14):5595-5598.
    [7]
    Bai YY.Studies on chemical constituents and bioactivities from the root bark of dictamnus dasycarpus(白鲜皮化学成分和药理活性研究)[D].Jinan:Jinan University,2014.
    [8]
    Li X,Tang HZ,Gou XJ,et al.Study on chemical constituents of the root of Dictamnus dasycarpus[J].Chin Med Mat J(中药材),2008,31(12):1816-1819.
    [9]
    Jeong SY,Sang HS,Young CK,et al.Neuroprotective limonoids of root bark of Dictamnus dasycarpus[J].J Nat Prod,2008,71(2):208-211.
    [10]
    Liu ZL,Xu YJ,Wu J,et al.Feeding deterrents from Dictamnus dasycarpus turcz against two stored-product insects[J].J Agric Food Chem,2002,50(6):1447-1450.
    [11]
    Kang SL,Wang SX,Zhu TR.Studies on active constituents of the root bark of Dictamnus dasycarpus Turcz[J].J Shenyang Coll Pharm(沈阳药学院学报),1983,6:11-16.
    [12]
    Fauvel MT,Gleye J,Moulis C,et al. Alkaloids and flavonoids of Melicope indica[J].Phytochemistry,1981,20(8):2059-2060.
    [13]
    Kazeem MI,Ogunbiyi JV,Ashafa AO.In vitro studies on the inhibition of α- amylase and α-glucosidase by leaf extracts of Picralima nitida(Stapf)[J].Trop J Pharm Res,2013,12(5):719-725.
  • Related Articles

    [1]YE Zhenning, WU Zhenghong, ZHANG Huaqing. Research progress of blood-brain barrier crossing strategies and brain-targeted drug delivery mediated by nano-delivery system[J]. Journal of China Pharmaceutical University, 2024, 55(5): 590-602. DOI: 10.11665/j.issn.1000-5048.2024052202
    [2]LUO Xuelian, WU Chengsheng, ZHA Cheng, LIU Sheng. Research progress and prospects of implantable drug delivery systems for postoperative tumor therapy[J]. Journal of China Pharmaceutical University, 2024, 55(4): 538-547. DOI: 10.11665/j.issn.1000-5048.2024040901
    [3]WANG Shihao, LIU Lifeng, DING Yang, LI Suxin. Research progress of pH-responsive drug delivery systems in cancer immunotherapy[J]. Journal of China Pharmaceutical University, 2024, 55(4): 522-529. DOI: 10.11665/j.issn.1000-5048.2024011902
    [4]YU Jiayu, LIN Zezhi, CAO Wei, ZHANG Jianjun, WEI Yuanfeng, GAO Yuan, QIAN Shuai. Research progress of bio-metal organic frameworks in drug delivery system[J]. Journal of China Pharmaceutical University, 2023, 54(1): 23-33. DOI: 10.11665/j.issn.1000-5048.20221111003
    [5]ZHOU Yeshu, WANG Yanmei, ZHANG Beiyuan, WU Shuaicong, YANG Lei, YIN Lifang. Research progress of inorganic nanomaterials in drug delivery system[J]. Journal of China Pharmaceutical University, 2020, 51(4): 394-405. DOI: 10.11665/j.issn.1000-5048.20200403
    [6]LI Haoxian, LIN Huaqing, CHEN Jingwen, WANG Liyuan. Research progress of carbon nanomaterials in cancer drug delivery[J]. Journal of China Pharmaceutical University, 2019, 50(1): 100-106. DOI: 10.11665/j.issn.1000-5048.20190114
    [7]FAN Qianqian, XING Lei, QIAO Jianbin, ZHANG Chenglu, JIANG Hulin. Advances in drug delivery systems for the treatment of liver fibrosis[J]. Journal of China Pharmaceutical University, 2018, 49(3): 263-271. DOI: 10.11665/j.issn.1000-5048.20180302
    [8]CHEN Xing, KANG Yang, WU Jun. Advances in biodegradable functional polymers based protein drug delivery system[J]. Journal of China Pharmaceutical University, 2017, 48(2): 142-149. DOI: 10.11665/j.issn.1000-5048.20170203
    [9]WANG Yazhe, ZHOU Jianping, DING Yang, WANG Wei. Advances in research of biomimetic drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(3): 267-273. DOI: 10.11665/j.issn.1000-5048.20140303
    [10]TANG Yue, KE Xue. Advances of mesoporous silica nanoparticles as drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(6): 567-572.
  • Cited by

    Periodical cited type(9)

    1. 蔡鸿飞,张琴,关伟键,杨阳,袁诚,许文东. 不同干燥方式对灵芝孢子粉中灵芝孢子油过氧化值的影响. 广东化工. 2024(01): 28-30 .
    2. 林志彬. 灵芝孢子油的药效物质基础研究进展. 菌物研究. 2024(01): 79-87 .
    3. Jianying Liu,Binzhi Zhang,Leqi Wang,Shasha Li,Qinqiang Long,Xue Xiao. Bioactive components, pharmacological properties and underlying mechanism of Ganoderma lucidum spore oil: A review. Chinese Herbal Medicines. 2024(03): 375-391 .
    4. 武美华,张胜男,敬隆鑫,律凤霞. 灵芝的活性成分及其药理作用的研究进展. 中国林副特产. 2023(02): 76-79 .
    5. 夏凤娜,关小莺,陈少丹,陈秋颜,张一帆,杨小兵. 灵芝孢子粉脂质成分HPLC-ELSD指纹图谱构建及含量测定. 食用菌学报. 2023(06): 52-59 .
    6. 井子良,吴纯宇,张慧敏,孙建博. 灵芝孢子油番茄红素复合物的抗肿瘤作用. 现代食品科技. 2022(09): 46-51 .
    7. 李志强,何玉霞. 灵芝多糖对人肺癌A549细胞增殖凋亡的作用. 现代食品科技. 2021(05): 38-42 .
    8. 张琴,李康强,杨阳,张圳,蔡鸿飞,许文东. 不同提取方式的灵芝孢子油品质研究. 广东化工. 2021(11): 48-49 .
    9. 包县峰,徐勇,刘维明,王星丽,孙培龙,张安强. 灵芝孢子粉生物活性成分及药理作用. 食品工业科技. 2020(06): 325-331 .

    Other cited types(6)

Catalog

    Article views (777) PDF downloads (979) Cited by(15)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return